Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

MFUS vs CANC overlap: 17% of top holdings shared

Bottom line

How much do MFUS and CANC overlap?

17% of their top holdings overlap by weight. 5 securities appear in both funds' top 25, making up 6.1% of MFUS's assets and 15.8% of CANC's. They are substantially different portfolios, so owning both adds real diversification.

MFUS holds far more positions (883 vs 57), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

MFUSCANC
Weight overlap (top 25)17%
Shared holdings5
Weight in shared holdings6.1%15.8%
Total positions88357
Expense ratio0.29%0.75%
Holdings as ofJun 30, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Holdings MFUS and CANC have in common

Holding% of MFUS% of CANCOverlap
Johnson & Johnson1.64%2.55%1.64%
Eli Lilly & Co1.42%4.82%1.42%
AbbVie Inc1.26%2.81%1.26%
Merck & Co Inc1.05%3.57%1.05%
Amgen Inc0.77%2.11%0.77%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in MFUS

  1. Intel Corp — 3.52%
  2. Walmart Inc — 1.70%
  3. Citigroup Inc — 1.56%
  4. Corning Inc — 1.54%
  5. Exxon Mobil Corp — 1.53%
  6. Applied Materials Inc — 1.49%
  7. Lam Research Corp — 1.47%
  8. Broadcom Inc — 1.46%
  9. Western Digital Corp — 1.35%
  10. Cisco Systems Inc — 1.34%
  11. Chevron Corp — 1.27%
  12. Apple Inc — 1.11%
  13. International Business Machines Corp — 1.07%
  14. Caterpillar Inc — 0.99%
  15. Berkshire Hathaway Inc — 0.98%

Only in CANC

  1. Revolution Medicines Inc — 7.73%
  2. Roche Holding AG — 4.21%
  3. Cogent Biosciences Inc — 4.10%
  4. Novartis AG — 4.03%
  5. Immunome Inc — 3.91%
  6. Celcuity Inc — 3.58%
  7. AstraZeneca PLC — 3.54%
  8. Nuvalent Inc — 3.37%
  9. Bristol-Myers Squibb Co — 3.30%
  10. Legend Biotech Corp — 2.99%
  11. Exelixis Inc — 2.78%
  12. Bridgebio Pharma Inc — 2.75%
  13. CG oncology Inc — 2.43%
  14. Genmab A/S — 2.37%
  15. Ideaya Biosciences Inc — 2.27%

Asset mix

Asset typeMFUSCANC
Stocks99.8%99.0%
Cash & short-term funds0.1%1.1%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Country mix

CountryMFUSCANC
US96.9%80.9%
CH0.3%8.2%
GB0.4%4.0%
DK—2.4%
CN—2.0%
IE1.4%—
DE—1.1%
JP—0.7%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Check another pair

FAQ

How much do MFUS and CANC overlap?
About 17% by weight. 5 securities appear in both funds' top 25 holdings; they make up 6.1% of MFUS's assets and 15.8% of CANC's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do MFUS and CANC have in common?
The largest shared holdings are Johnson & Johnson, Eli Lilly & Co, AbbVie Inc, Merck & Co Inc, Amgen Inc.
Should I own both MFUS and CANC?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, MFUS or CANC?
MFUS is broader, with 883 positions versus 57 for CANC. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.